Transfusion‐related immunomodulation: review of the literature and implications for pediatric critical illness

Citations Over TimeTop 10% of 2016 papers

Abstract

Transfusion-related immunomodulation (TRIM) in the intensive care unit (ICU) is difficult to define and likely represents a complicated set of physiologic responses to transfusion, including both proinflammatory and immunosuppressive effects. Similarly, the immunologic response to critical illness in both adults and children is highly complex and is characterized by both acute inflammation and acquired immune suppression. How transfusion may contribute to or perpetuate these phenotypes in the ICU is poorly understood, despite the fact that transfusion is common in critically ill patients. Both hyperinflammation and severe immune suppression are associated with poor outcomes from critical illness, underscoring the need to understand potential immunologic consequences of blood product transfusion. In this review we outline the dynamic immunologic response to critical illness, provide clinical evidence in support of immunomodulatory effects of blood product transfusion, review preclinical and translational studies to date of TRIM, and provide insight into future research directions.

Related Papers

• → Nutritional Support of the Critically Ill Pediatric Patient: Foundations and Controversies(2017)9 cited
• → Assessment of adrenocortical function in the critically ill(2005)21 cited
• → Is massage beneficial to critically ill patients in intensive care units? A critical review(1994)2 cited
• → PP041-SUN THE SEVERITY OF ILLNESS AND PROTEIN DELIVERY IN CRITICALLY ILL PATIENTS(2012)